the market doesn't think it's anything to get excited about and until they do it's worth only what a buyer is prepared to pay which currently isn't much
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025